Axsome Therapeutics Inc (LTS:0HKF)
$ 94.03 3.1 (3.41%) Market Cap: 4.48 Bil Enterprise Value: 4.36 Bil PE Ratio: 0 PB Ratio: 44.86 GF Score: 36/100

Axsome Therapeutics Inc Solriamfetol Investor Day Transcript

Dec 07, 2023 / 01:00PM GMT
Release Date Price: $70.76 (+0.61%)
Operator

Good morning and welcome to the Axsome Therapeutics conference call. Currently, all participants are in a listen only mode. Later there will be a question-and -answer session. As a reminder, today's conference is being recorded.

I would now like to turn the conference over to Darren Opland, Director, Corporate Communications at Axsome Therapeutics. Thank you. Please go ahead.

Darren Opland Axsome Therapeutics
Inc. - Director, Corporate Communications

Good morning, and thank you all for joining us for today's Solriamfetol Investor Event Conference Call. During today's call, we will be making certain forward looking statements. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our investigational agents, our clinical and nonclinical plans, our plans to present oor report additional data, the anticipated conduct and the source of future clinical trials regulatory plans, future research and development plans, our commercial plans regarding Sunosi ability and our pipeline products,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot